| Amrutanjan Health Care Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 590006 |
NSE Symbol : AMRUTANJAN |
P/E(TTM) : 33.42 |
|
ISIN Demat : INE098F01031 |
Div & Yield% : 0.70 |
EPS(TTM) : 19.61 |
|
Book Value(₹) : 118.32 |
Market Cap(₹Cr) : 1,894.66 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 117.70 | 94.05 | 135.41 | 122.75 | 109.92 | 83.74 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 117.70 | 94.05 | 135.41 | 122.75 | 109.92 | 83.74 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 4.30 | 4.43 | 4.82 | 4.36 | 4.05 | 4.45 |
| Total Income | 122.00 | 98.47 | 140.23 | 127.11 | 113.96 | 88.19 |
| Total Expenditure | 101.17 | 85.60 | 117.71 | 99.40 | 96.31 | 80.19 |
| PBIDT | 20.82 | 12.87 | 22.52 | 27.71 | 17.65 | 8.00 |
| Interest | 0.05 | 0.05 | 0.04 | 0.06 | 0.06 | 0.06 |
| PBDT | 20.77 | 12.82 | 22.48 | 27.65 | 17.59 | 7.94 |
| Depreciation | 1.56 | 1.53 | 1.62 | 1.66 | 1.65 | 1.59 |
| Tax | 5.25 | 2.98 | 5.68 | 6.74 | 4.14 | 1.73 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 13.96 | 8.31 | 15.18 | 19.25 | 11.80 | 4.62 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 13.96 | 8.31 | 15.18 | 19.25 | 11.80 | 4.62 |
| EPS (Unit Curr.) | 4.83 | 2.87 | 5.25 | 6.66 | 4.08 | 1.60 |
| EPS (Adj) (Unit Curr.) | 4.83 | 2.87 | 5.25 | 6.66 | 4.08 | 1.60 |
| Calculated EPS (Unit Curr.) | 4.83 | 2.87 | 5.25 | 6.66 | 4.08 | 1.60 |
| Calculated EPS (Adj) (Unit Curr.) | 4.83 | 2.87 | 5.25 | 6.66 | 4.08 | 1.60 |
| Calculated EPS (Ann.) (Unit Curr.) | 19.32 | 11.50 | 21.00 | 26.63 | 16.32 | 6.39 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 19.32 | 11.50 | 21.00 | 26.63 | 16.32 | 6.39 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 100.00 | 0.00 | 0.00 | 100.00 | 0.00 | 100.00 |
| Equity | 2.89 | 2.89 | 2.89 | 2.89 | 2.89 | 2.89 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 17.69 | 13.68 | 16.63 | 22.57 | 16.06 | 9.55 |
| PBDTM(%) | 17.65 | 13.63 | 16.60 | 22.53 | 16.00 | 9.48 |
| PATM(%) | 11.86 | 8.84 | 11.21 | 15.68 | 10.74 | 5.52 |